Previous 10 | Next 10 |
Orion Group Holdings, Inc. (NYSE: ORN) (the "Company") a leading specialty construction company, today announced contract awards totaling approximately $17 million. The Company’s Marine segment has been awarded two separate contracts to provide dredging services in the Corpus Chris...
Will receive € 0.7 million public funding from the Spanish Ministry of Science and Innovation In collaboration with the Research Institute of the Hospital de la Vall d’Hebrón in Barcelona (VHIR) MADRID, Spain and CAMBRIDGE, Mass., June 15, 2020 (GLOBE NEWSWIRE)...
Robust signals of clinical efficacy, with ORR of 77%, of which 60% are CR/CRi Fast clinical responses, with mean time to response of 37 days Longest remission to date 488 days, still ongoing Iadademstat and azacitidine combination shows a good safety profile Results presente...
Elective move to boost current revolver of $50 million by $20 million is positive. The move was elective and it adds to previous liquidity of $25.6 million. Free cash flow was strong in 1Q2020, but cash management is important in the current environment, and capex and other spending, includ...
Orion Group Holdings (NYSE: ORN ) has entered into an amendment with Regions Bank and other lenders, providing for a new $20M revolving credit facility to supplement its existing $50M revolver. More news on: Orion Group Holdings, Inc., Read more ...
Orion Group Holdings, Inc. (NYSE: ORN) (the "Company") a leading specialty construction company, today announced it has entered into an amendment to its existing credit agreement with Regions Bank and other lenders, providing for a new $20 million revolving credit facility to supplement its e...
The company will also present at the Jefferies 2020 Global Healthcare Conference MADRID, Spain and CAMBRIDGE, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop th...
Pharmacology and preclinical efficacy reported in rodent models of cognition and behavior Detailed insight into mechanism of action MADRID, Spain and CAMBRIDGE, Mass., June 01, 2020 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biophar...
Orion Group Holdings, Inc. (NYSE: ORN) (the "Company") a leading specialty construction company, today announced a contract award totaling approximately $30 million. The Company’s concrete segment has been awarded a contract for the construction of a multi-use tower structure locat...
MADRID, Spain and CAMBRIDGE, Mass., May 18, 2020 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the enrollment...
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE:ORN) (the "Company"), a leading specialty construction company, today...
HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today announced a significant contract award valued at nearly $80 million for its Marine construction business. The contract was awarded by Por...
Bio-Equity Europe 2024 Asebio Investor Day 2024 RSC Hot Topics: Covalent Drug Discovery Foro Medcap BME 2024 MADRID, Spain and CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutica...